| Evidence of escape of SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera D Zhou, W Dejnirattisai, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... Cell 184 (9), 2348-2361. e6, 2021 | 1186 | 2021 |
| The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution R Acharya, E Fry, D Stuart, G Fox, D Rowlands, F Brown Nature 337 (6209), 709-716, 1989 | 1134 | 1989 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 989 | 2022 |
| Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum C Liu, HM Ginn, W Dejnirattisai, P Supasa, B Wang, A Tuekprakhon, ... Cell 184 (16), 4220-4236. e13, 2021 | 781 | 2021 |
| Antibody evasion by the P. 1 strain of SARS-CoV-2 W Dejnirattisai, D Zhou, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... Cell 184 (11), 2939-2954. e9, 2021 | 679 | 2021 |
| Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ... Cell 185 (14), 2422-2433. e13, 2022 | 674 | 2022 |
| Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1 J Martinez-Picado, JG Prado, EE Fry, K Pfafferott, A Leslie, S Chetty, ... Journal of virology 80 (7), 3617-3623, 2006 | 556 | 2006 |
| Reduced neutralization of SARS-CoV-2 B. 1.1. 7 variant by convalescent and vaccine sera P Supasa, D Zhou, W Dejnirattisai, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... Cell 184 (8), 2201-2211. e7, 2021 | 508 | 2021 |
| Structure of a major immunogenic site on foot-and-mouth disease virus D Logan, R Abu-Ghazaleh, W Blakemore, S Curry, T Jackson, A King, ... Nature 362 (6420), 566-568, 1993 | 499 | 1993 |
| A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71 X Wang, W Peng, J Ren, Z Hu, J Xu, Z Lou, X Li, W Yin, X Shen, C Porta, ... Nature structural & molecular biology 19 (4), 424-429, 2012 | 444 | 2012 |
| The structure and function of a foot‐and‐mouth disease virus–oligosaccharide receptor complex EE Fry, SM Lea, T Jackson, JWI Newman, FM Ellard, WE Blakemore, ... The EMBO journal, 1999 | 395 | 1999 |
| Neutralization of SARS-CoV-2 by destruction of the prefusion spike J Huo, Y Zhao, J Ren, D Zhou, HME Duyvesteyn, HM Ginn, L Carrique, ... Cell host & microbe 28 (3), 445-454. e6, 2020 | 392 | 2020 |
| The antigenic anatomy of SARS-CoV-2 receptor binding domain W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn, P Supasa, JB Case, ... Cell 184 (8), 2183-2200. e22, 2021 | 379 | 2021 |
| The structure and antigenicity of a type C foot-and-mouth disease virus S Lea, J Hernéndez, W Blakemore, E Brocchi, S Curry, E Domingo, E Fry, ... Structure 2 (2), 123-139, 1994 | 314 | 1994 |
| The nsp9 replicase protein of SARS-coronavirus, structure and functional insights G Sutton, E Fry, L Carter, S Sainsbury, T Walter, J Nettleship, N Berrow, ... Structure 12 (2), 341-353, 2004 | 305 | 2004 |
| Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient D Zhou, HME Duyvesteyn, CP Chen, CG Huang, TH Chen, SR Shih, ... Nature structural & molecular biology 27 (10), 950-958, 2020 | 304 | 2020 |
| Structure and receptor binding T Jackson, AMQ King, DI Stuart, E Fry Virus research 91 (1), 33-46, 2003 | 262 | 2003 |
| Toremifene interacts with and destabilizes the Ebola virus glycoprotein Y Zhao, J Ren, K Harlos, DM Jones, A Zeltina, TA Bowden, ... Nature 535 (7610), 169-172, 2016 | 241 | 2016 |
| Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus N Parry, G Fox, D Rowlands, F Brown, E Fry, R Acharya, D Logan, ... Nature 347 (6293), 569-572, 1990 | 235 | 1990 |
| Crystal structure of SIV matrix antigen and implications for virus assembly Z Rao, AS Belyaev, E Fry, P Roy, IM Jones, DI Stuart Nature 378 (6558), 743-747, 1995 | 230 | 1995 |
